Dexamfetamine
Also known as: Dexamphetamine
Background
Listing
- Schedules
- Schedule 6 to 7, conditions apply
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
The ingredient index links no registered medicine to Dexamfetamine (register of 13 September 2026).
Counted through the register's ingredient index, which does not reach every record.
Regulatory status
Where S6 to S7 sits on the scale
Depends on which listing applies
At the least restrictive, Schedule 6: prescription-only, no repeats without a new prescription. At the most restrictive, Schedule 7: prohibited outside a government permit. The listings below say which applies to which form, strength or pack size.
Schedule S6 to S7, as the Consolidated Schedules list it.
Who may supply: Nobody, except under a permit issued by the Director-General. The Director-General may also authorise a medical practitioner, analyst, researcher or veterinarian to acquire or use it, on prescribed conditions, for the treatment or prevention of a medical condition in a particular patient, or for education, analysis or research. An ordinary prescription does not apply.
Consolidated Schedules listings for Dexamfetamine
S7: Dexamfetamine (Dexamphetamine)
- except in medicines registered in terms of the Act and intended for the treatment of Attention-Deficit Hyperactivity Disorder (S6)
Consolidated Schedules 06 July 2026, lines 10628 to 10629
S6: Dexamfetamine (Dexamphetamine)
- in medicines registered in terms of the Act and intended for the treatment of Attention-Deficit Hyperactivity Disorder. (S7)
Consolidated Schedules 06 July 2026, lines 10151 to 10152
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.